Showing 1631-1640 of 10608 results for "".
Physician Spotlight: Eric Schweiger, MD
Founder & CEO of Schweiger Dermatology Grouphttps://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-eric-schweiger-mdbrfounder-amp-ceo-of-schweiger-dermatology-group/23784/Successful Meetings: It's All About the Follow-up
https://practicaldermatology.com/topics/practice-management/successful-meetings-its-all-about-the-follow-up/20456/Frustrated by meetings that are run well but produce limited results? Then try keeping an eye on what happens afterwards.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/series/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-meet-crown-aesthetics-revance-to-market-teoxane-fillers-almirall-collaborates/19719/On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine. A fourLong-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review
https://practicaldermatology.com/programs/practical-dermatology/cutaneous-signet-ring-squamous-cell-carcinoma-case-presentation-and-brief-literature-review/24026/An in-depth look at the clinical presentation of this rare tumor type.A Growing Armamentarium for Psoriasis: How to Choose the Right Treatment for Each Patient
https://practicaldermatology.com/topics/psoriasis/a-growing-armamentarium-for-psoriasis-how-to-choose-the-right-treatment-for-each-patient/18214/Erin Boh, MD joins host Joshua Zeichner, MD in this edition of DermTube Journal Club to offer tips for navigating all the new and existing treatment options for patients with moderate to severe psoriasis. With so many effective options on the market, Dr. Boh says it's possible to find the best fit fOnline Reputation Management Update
https://practicaldermatology.com/topics/practice-management/online-reputation-management-update/18658/Protecting your online reputation is crucial to your digital marketing success. If you think it's all about spotting and hiding bad reviews, you're wrong. Learn how to build and protect a stellar online reputation for your dermatology practice and how it will actually boost SEO. The Ekwa Marketing tUse of Hylenex to Treat Microstomia in CREST Syndrome: A Case Study and Call to Action
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23915/Physician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/